三维适形放疗联合中药紫龙金治疗老年中晚期NSCLC临床观察.docVIP

三维适形放疗联合中药紫龙金治疗老年中晚期NSCLC临床观察.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
三维适形放疗联合中药紫龙金治疗老年中晚期NSCLC临床观察

第三届国际中医、中西医结合肿瘤学术交流大会暨第十二届全国中西医结合肿瘤学术大会 三维适形放疗联合中药紫龙金治疗老年中晚期NScLC 临床观察 李维廉王风玮朱思伟王辉姚嫱秦玉坤 摘要目的:观察三维适形放疗(3D-CRT)联合中药紫金龙治疗70岁以上老年中晚期非 小细胞肺癌(NSCLC)的疗效和耐受性。方法:37例中晚期NSCLC随机分为治疗组19?哉兆椋保咐阶榫邮埽常模茫遥?2GY/F每日1次,每周5次至DT 60—64GY。治疗组加服 中药紫龙金4片t.i.d至放疗结束后2周,对照组单接受放疗。结果:治疗组和对照组近期有效率分别为63.2%和50.0%(P=0.19);l、2年病灶局部控制率(DCR)分别为73.6%,47.3% (P<0.05=和44.2%,22.2%(P=0.08),主要毒副反应为骨髓抑制、消化道反应以及放射性食管炎、放射性肺炎,QOL治疗组优于对照组。结论:3D-CRT联合中药紫龙金治疗70岁以上晚期NSCLC能明显提高患者一年疾病局部控制率,改善KPS,增加体重,不良反应较轻,老年患者易于接受。 关键词 老年非小细胞肺癌 三维适形放射治疗 中药紫龙金 To Evaluate the Efficacy and Toxicities of 3D—CRT Combined with TCM—Zilongjin Tab.onAdvanced Elderly NSCLC Patients LI Weilian,WANG Fengwei,ZHU siwei,WANG Hui,YAO Qiang,Q矾Yukun Abstract Objective:To evaluate the efficacy and toxicities of three—dimensionalradiotherapy(3D—CRT)combine with TCM Zilongjin Tab.for stage HI—IV NSCLC.Method:Atotal of thirty seven elderly(>70year old)patients with advanced NSCLC were randomly assigned Group 19 patients and controlto the treatment 18 patients.Both groups were received group3D—CRT with a total dose of 60—64Gy,2.0Gy/fraction,once a daily,5times per week.Patients in thetreatment group were treated with radiotherapy combined TCM-Zilongjin 4 Tab.t.i.d until the end.one and two years disease control rate(DCR),quality of life(QOL)and peripheral blood wereexamined after treatment.Results:No significant difference were found in RR between thetreatment group and control group(p=O.19),one and two year DCR were 73.6%VS 44.4%(P<0.05=and 47.3%VS 22.2%(P=O.08),respectively;QOL,symptoms improved and body weightinerese in the treatment group were superior to those in the control group.Adverse events weregenerally mild in treatment group,the rate of leucopenia,decrease in hemoglobin and severe acuteradiation induced pneumonitis and esophagitis were higher in control group.Conclusion:Thetreatment of 3D··CRT combine with TCM·-Zilongjin shown an effective antitumor activity and afavorable toxicity profile in elderly patients with NSCLC. Keywords 3DCRT;TC

文档评论(0)

小教资源库 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档